This chemical is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly valuable in the development of drugs targeting neurological disorders, due to its structural properties that can influence receptor activity. Additionally, it is used in research settings for the preparation of chiral compounds, where its stereochemistry plays a crucial role in the study of enantioselective reactions. Its trifluoromethyl group enhances the compound's metabolic stability, making it a key component in the design of more effective and durable therapeutic agents.